{
    "id": 24947,
    "cites": 28,
    "cited_by": 9,
    "reference": [
        "Bao, Y,, Pan, Y., Taylor, A, Radakrishman, S., Luo, F., Pincus, H.A. & Schackman, B.R.. (2016). Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. Health Affairs, 35(6), 1045-1051.",
        "Blank, Rebecca M. (2002). Evaluating Welfare Reform in the United States. J. of Econ Lit., v. 40, n.4, 1105-1166.",
        "Buchmueller, T.C. & Carey, C. (2018). The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare. Amer. J. Econ. J.: Econ Pol\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2y. 10(1), 77-112.",
        "Brandeis University Prescription Drug Monitoring Program Training and Technical Assistance Center. (n.d.) PDMP Legislation & Operational Dates. Retrieved from http://www.pdmpassist.org/content/pdmp-legislation-operational-dates Case, A. & Deaton, A. (2015). Rising Morbidity and Mortality in Midlife among White NonHispanic Americans in the 21st Century. Proceedings of the Nat. Acad. Sciences. 112(49) 1507815083.",
        "Centers for Disease Control. (n.d.) 10 Leading Causes of Death by Age Group, United States\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d2016. Retrieved from https://www.cdc.gov/injury/wisqars/pdf/leading_causes_of_death_by_age_group_2016-508.pdf Centers for Disease Control. (n.d.) 10 Leading Causes of Injury Deaths by Age Group Highlighting Unintentional Injury Deaths, United States\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d2016. Retrieved from https://www.cdc.gov/injury/wisqars/pdf/leading_causes_of_injury_deaths_highlighting_unintenti onal_injury_2016-508.pdf Centers for Disease Control. (2017) Underlying Cause of Death, 1999-2016 [Data file].",
        "Retrieved from https://wonder.cdc.gov/controller/saved/D76/D15F907 Davis, C.S., Pierce, M., Dasgupta, N. (2014). Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011. American Journal of Public Health, 104(8), 1389-1395.",
        "Davis, C.S. (2017). Commentary on Pardo (2017) and Moyo et al. (2017): Much Still Unknown about Prescription Drug Monitoring Programs. Addiction. 112(10),1797-1798.",
        "Deyo, R.A., Irvine, J.M., Millet, L.M., Beran, T., O\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2Kane, N., Wright, D.A. & McCarty, D.. (2013). Measures Such As Interstate Cooperation Would Improve The Efficacy Of Programs To Track Controlled Drug Prescriptions. Health Affairs, 32(3), 603-613.",
        "Dowell, D., Arias, E., Kochanek, K., Anderson, R., Guy, G.P. Jr., Losby, J.L. & Baldwin, G. (2017). Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015. JAMA, 318(11), 1065-1067. (\u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug-poisoning deaths contributed a loss of 0.28 years in life expectancy. Most of this loss (96%) was unintentional; 0.21 years were lost to opioid-involved poisoning deaths.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d) Dowell, D., Zhang, K., Noonan, R.K., Hockenberry J.M. (2016). Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates. Health Affairs, 35(10), 1876-1883.",
        "Farley, J. (2011, October 14). State to begin monitoring prescriptions for pain medication in 2012, Kitsap Sun. Retrieved from https://1.next.westlaw.com Guy, G.P. Jr., Zhang, K., Bohm, M.K., Losby, J., Lewis, B., Young, R\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6 & Dowell, D.. Vital signs: changes in opioid prescribing in the United States, 2006-2015. Morbidity and Mortality Weekly Report (MMWR), 66(26), 697-704.",
        "Harshman, M. (2011, October 18). State to start monitoring prescriptions. Columbian, p. E.",
        "Hartzema, A.G. (1992). Impact of Triplicate Prescription Program on Psychotropic Prescribing Patterns in Long-Term Care Facilities. Annals of Pharmacotherapy, 26(4), 539-546.",
        "Hedegaard, H., Warner, M. & Mini\u00c3\u0083\u00c2\u00b1o, A. (2017) Drug Overdose Deaths in the United States, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2016. Retrieved from National Center for Health Statistics https://www.cdc.gov/nchs/products/databriefs/db294.htm.",
        "Ho, V. (2008, December 11). Health Plans to be Pared, Two Potential Lifesavers Go. Seattle Post-Intelligencer, p. A13.",
        "Kunins, H.V., Farley, T.A., & Dowell, D. (2013). Guidelines for opioid prescription: why emergency physicians need support, Annals of Internal Medicine, 158(11), 841-842.",
        "Massachusetts, 105 Mass. Code Regs. 700.006(J)(1)(c) (2004) (current version at 105 Mass. Code Regs. 700.012(A)(5)).",
        "Meara, E., Horwitz, J.R., Powell, W., McClelland, L., Zhou, W., O'Malley, J., Morden, N.E.. (2016). State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. New England J. Med., 375, 44-53.",
        "Morgan, L., Weaver, M., Sayeed, Z. & Orr, R. (2012). The Use of Prescription Monitoring Programs to Reduce Opioid Diversion and Improve Patient Safety. Journal of Pain & Palliative Care Pharmacotherapy, 27(1), 4-9.",
        "Nam, Y.H., Shea, D.G., Shi, Y. & Moran, J.R. (2017). State Prescription Drug Monitoring Programs and Fatal Drug Overdoses. The American Journal of Managed Care, 23(5), 297-303.",
        "National Alliance for Model State Drug Laws. (2014). PDMP Dates of Operation. Retrieved from http://www.namsdl.org/library/580225E9-E469-AFA9-50E7579C1D738E71/ Department of Health and Human Services Office of the Inspector General. (1992). Multiple Copy Prescription Programs: State Experiences. Retrieved from https://oig.hhs.gov/oei/reports/oei-12-91-00490.pdf Pardo, B. (2017). Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction, 112(10), 1773-1783.",
        "Patrick, S.W., Fry, C.E., Jones T.F., & Buntin, M.B.. (2016). Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. Health Affairs, 35(7), 1324-1332.",
        "Prescription Drug Abuse Policy System. (2017, June 1). PDMP Implementation Dates.",
        "Retrieved from http://www.pdaps.org/datasets/pdmp-implementation-dates Paulozzi, L.J., Kilbourne, E.M. & Desai, H.A. (2011). Prescription Drug Monitoring Programs and Death Rates from Drug Overdose. Pain Medicine, 12(5), 747-754.",
        "Ramanathan, T., Hulkower, R., Holbrook, J. & Penn, M. (2017). Legal Epidemiology: The Science of Law. The Journal of Law, Medicine & Ethics, 45(S1), 69-72.",
        "Sigler, K.A., Guernsey, B.G., Ingrim, N.B., Buesing, A.S., Hokanson, J.A., Galvan, E. & Doutre, W.H. (1984). Effect of a triplicate prescription law on prescribing of Schedule II drugs. American Journal of Health-System Pharmacy, 41(1), 108-111.",
        "Simoni-Wastila, L., Ross-Degnan, D., Mah, C., Gao, X., Brown, J., Cosler, L.E\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6Soumerai, S.B. (2004). A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clinical Theraputics, 26(2), 322-336.",
        "Simoni-Wastila, L. & Qian, J. (2012). In\u00c3\u00af\u00c2\u00ac\u00e2\u0080\u009auence of prescription monitoring programs on analgesic utilization by an insured retiree population. Pharmacoepidemiology and Drug Safety, 21, 1261-1268.",
        "Weintraub, M., Singh, S., Byrne, L., Maharaj, K. & Guttmacher, L. (1991). Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations. JAMA, 266(17), 2392-2397."
    ]
}